Linagliptin monotherapy in type 2 diabetes patients for whom metformin is inappropriate: an 18-week randomized, double-blind, placebo-controlled phase III trial with a 34-week active-controlled extension-Reference-Cited by-同舟云学术

Linagliptin monotherapy in type 2 diabetes patients for whom metformin is inappropriate: an 18-week randomized, double-blind, placebo-controlled phase III trial with a 34-week active-controlled extension

Published:2012-10-01 Issue:12 Volume:14 Page:1145-1154
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Barnett A. H.¹,Patel S.²,Harper R.²,Toorawa R.²,Thiemann S.³,von Eynatten M.³,Woerle H.-J.³

Affiliation:

1. Diabetes Centre; Heart of England NHS Foundation Trust and University of Birmingham; Birmingham UK

2. Boehringer Ingelheim; Bracknell UK

3. Boehringer Ingelheim; Ingelheim Germany

Funder

Boehringer Ingelheim Pharma GmbH & Co. KG

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12011/fullpdf

Reference45 articles.

1. Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control;Rodbard;Endocr Pract,2009

2. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Inzucchi;Diabetes Care,2012

3. Metformin--the gold standard in type 2 diabetes: what does the evidence tell us?;Bosi;Diabetes Obes Metab,2009

4. An energetic tale of AMPK-independent effects of metformin;Miller;J Clin Invest,2010

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Water in nigella oil microemulsion for enhanced oral bioavailability of linagliptin;Drug Delivery and Translational Research;2024-05-13

2. Safety of Linagliptin in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Clinical Trials;Therapeutic Innovation & Regulatory Science;2024-04-18

3. Comparison of gliclazide vs linagliptin on hypoglycemia and cardiovascular events in type 2 diabetes mellitus: A systematic review;World Journal of Diabetes;2022-12-15

4. Choice of Glucose-Lowering Drugs as Initial Monotherapy for Type 2 Diabetes Patients with Contraindications or Intolerance to Metformin: A Systematic Review and Meta-Analysis;Journal of Clinical Medicine;2022-11-30

5. DPP‐4 Inhibitors;Diabetes Drug Notes;2022-06-27